Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis

2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite of 17β-estradiol, is known to induce mitochondria-mediated apoptosis through several mechanisms. We sought to study the effect of mitochondrialy targeted hOGG1 (MTS- hOGG1 ) on HeLa cells exposed to 2-ME. MTS- hOGG1 -expressing cells expos...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogene Ročník 27; číslo 26; s. 3710 - 3720
Hlavní autoři: Chatterjee, A, Chang, X, Nagpal, J K, Chang, S, Upadhyay, S, Califano, J, Trink, B, Sidransky, D
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 12.06.2008
Nature Publishing
Nature Publishing Group
Témata:
ISSN:0950-9232, 1476-5594, 1476-5594
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite of 17β-estradiol, is known to induce mitochondria-mediated apoptosis through several mechanisms. We sought to study the effect of mitochondrialy targeted hOGG1 (MTS- hOGG1 ) on HeLa cells exposed to 2-ME. MTS- hOGG1 -expressing cells exposed to 2-ME showed increased cellular survival and had significantly less G 2 /M cell cycle arrest compared to vector-only-transfected cells. In addition, 2-ME exposure resulted in an increase in mitochondrial membrane potential, increased apoptosis, accompanied by higher activation of caspase-3, -9, cleavage of Bid to tBid and protein poly(ADP-ribose) polymerase (PARP) cleavage in HeLa cells lacking MTS- hOGG1 . Fas inhibitors cerulenin or C75 inhibited 2-ME-induced caspase activation, PARP cleavage, apoptosis and reversed mitochondrial membrane hyperpolarization, thereby recapitulating the increased expression of MTS- hOGG1 . Hence, MTS- hOGG1 plays an important protective role against 2-ME-mediated mitochondrial damage by blocking apoptosis induced through the Fas pathway.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0950-9232
1476-5594
1476-5594
DOI:10.1038/onc.2008.3